Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
470.60    0.60 (0.13%)
Bid:
469.80
Ask:
470.20
Spread: 0.40 (0.085%)
Market Cap: £2.43b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Buyback Programme 3rd Tranche

3 Feb 2025 07:00

RNS Number : 5563V
QinetiQ Group plc
03 February 2025
Ā 

News release

QinetiQ Group plc

Commencement of Third Tranche of Buyback Programme

3 February 2025 - QinetiQ Group plc ("QinetiQ" or the "Group") confirms the completion by Numis Securities Limited ("Deutsche Numis") of the second tranche of its £100 million share buyback programme (the "Programme") announced on 16 January 2024. As announced on 14 November 2024, QinetiQ is extending the Programme by £50m to deliver increased shareholder returns.

QinetiQ has today entered into an agreement with Deutsche Numis to extend the Programme through the execution of a third tranche ("the Third Tranche) with a maximum aggregate value of up to £50 million. Under the Third Tranche, which is expected to complete by no later than 30 June 2025, Deutsche Numis will make trading decisions independently of QinetiQ in accordance with certain pre-set parameters. The Third Tranche will be effected under the authority granted by shareholders at QinetiQ's Annual General Meeting held on 18 July 2024, and the maximum remaining number of shares that may be repurchased under the Third Tranche pursuant to that authority is 42,778,600 Ordinary Shares.

Any purchases under the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with the Buyback Authority, Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse (Amendment) (EU Exit) Regulations 2019.

Any Ordinary Shares purchased pursuant to the Programme will be cancelled, and the number of Ordinary Shares in issue reduced accordingly.

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

Stephen Lamacraft, Group Interim Director Investor Relations: +44 (0) 7471 885817

Lindsay Walls, Group Communications Director (Media enquiries): +44 (0) 7793 427582

James Field, Company Secretary: +44 (0) 7841 662957

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
MSCDGGDDCGGDGUB
Date   Source Headline
5th May 20174:42 pmRNSBlock listing Interim Review
12th Apr 20174:12 pmRNSDirector/PDMR Shareholding
31st Mar 20173:03 pmRNSTotal Voting Rights
28th Mar 20171:47 pmRNSTransaction in Own Shares 27 Mar 17 - Replacement
27th Mar 20175:48 pmRNSTransaction in Own Shares
24th Mar 20175:13 pmRNSTransaction in Own Shares
23rd Mar 20175:34 pmRNSTransaction in Own Shares
22nd Mar 20175:45 pmRNSTransaction in Own Shares
21st Mar 20175:31 pmRNSTransaction in Own Shares
20th Mar 20175:18 pmRNSTransaction in Own Shares
17th Mar 20175:53 pmRNSTransaction in Own Shares
16th Mar 20175:49 pmRNSTransaction in Own Shares
10th Mar 20173:17 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSTotal Voting Rights
27th Feb 20175:01 pmRNSTransaction in Own Shares
24th Feb 20175:09 pmRNSTransaction in Own Shares
23rd Feb 20175:08 pmRNSTransaction in Own Shares
22nd Feb 20175:20 pmRNSTransaction in Own Shares
21st Feb 20175:12 pmRNSTransaction in Own Shares
15th Feb 20177:00 amRNSThird Quarter Trading Update
13th Feb 20173:00 pmRNSDirector/PDMR Shareholding
10th Feb 20171:51 pmRNSDirector/PDMR Shareholding
31st Jan 20175:06 pmRNSTransaction in Own Shares
31st Jan 201711:00 amRNSTotal Voting Rights
30th Jan 20175:19 pmRNSTransaction in Own Shares
27th Jan 20175:05 pmRNSTransaction in Own Shares
26th Jan 20175:08 pmRNSTransaction in Own Shares
26th Jan 20178:00 amRNSChange of Auditor
25th Jan 20175:19 pmRNSTransaction in Own Shares
24th Jan 20175:22 pmRNSTransaction in Own Shares
16th Jan 20174:17 pmRNSDirector/PDMR Shareholding
10th Jan 20174:04 pmRNSDirector/PDMR Shareholding
6th Jan 20179:47 amRNSConfirmation of Date of Appointment of CFO
21st Dec 20167:00 amRNSQinetiQ acquires Meggitt Target Systems
12th Dec 20164:11 pmRNSDirector/PDMR Shareholding
12th Dec 20164:09 pmRNSDirector/PDMR Shareholding
12th Dec 20164:06 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSQinetiQ secures £1bn LTPA contract amendment
1st Dec 20167:00 amRNSTotal Voting Rights
17th Nov 20167:00 amRNSHalf-year Report
11th Nov 201610:44 amRNSDirector/PDMR Shareholding
11th Nov 201610:40 amRNSDirector/PDMR Shareholding
2nd Nov 20165:00 pmRNSTransaction in Own Shares
1st Nov 201610:46 amRNSTotal Voting Rights - Amending Announcement
1st Nov 20169:29 amRNSTotal Voting Rights
1st Nov 20167:00 amRNSBlock listing Interim Review
31st Oct 20165:23 pmRNSTransaction in Own Shares
28th Oct 20165:02 pmRNSTransaction in Own Shares
27th Oct 20165:09 pmRNSTransaction in Own Shares
26th Oct 20165:18 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.